India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country. Pfizer sought a patent that covers an important chemical formulation of the active compound…
阅读更多
辉瑞公司档案中的最新内容,,en,访问国际专利辉瑞公司档案,,en - 获得国际专利